Retina Synthesis

EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD


Episode Artwork
1.0x
0% played 00:00 00:00
Apr 04 2024 21 mins  
Other Episodes

We discuss remarkable preliminary results from the the use of intravitreal EYE-103, a novel Wnt pathway agonist in the treatment of DME and neovascular AMD with Dr. Charles Wykoff of Houston Texas.

Download episode Share
Copy URL



Subscribe on Podcast Addict